Form 8-K - Current report:
SEC Accession No. 0001104659-21-140869
Filing Date
2021-11-18
Accepted
2021-11-18 07:01:11
Documents
14
Period of Report
2021-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133361d1_8k.htm   iXBRL 8-K 25575
2 EXHIBIT 99.1 tm2133361d1_ex99-1.htm EX-99.1 15608
6 GRAPHIC tm2133361d1_ex99-1img001.jpg GRAPHIC 11419
  Complete submission text file 0001104659-21-140869.txt   233924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fold-20211118.xsd EX-101.SCH 3055
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20211118_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20211118_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2133361d1_8k_htm.xml XML 3480
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 211422583
SIC: 2834 Pharmaceutical Preparations